EBS logo

Emergent BioSolutions Inc. (EBS) Revenue

Annual Revenue:

$1.04B-$5.70M(-0.54%)
December 31, 2024

Summary

  • As of today, EBS annual revenue is $1.04 billion, with the most recent change of -$5.70 million (-0.54%) on December 31, 2024.
  • During the last 3 years, EBS annual revenue has fallen by -$730.00 million (-41.16%).
  • EBS annual revenue is now -41.16% below its all-time high of $1.77 billion, reached on December 31, 2021.

Performance

EBS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEBSincome statement metrics

Quarterly Revenue:

$231.10M+$90.20M(+64.02%)
September 30, 2025

Summary

  • As of today, EBS quarterly revenue is $231.10 million, with the most recent change of +$90.20 million (+64.02%) on September 30, 2025.
  • Over the past year, EBS quarterly revenue has dropped by -$62.70 million (-21.34%).
  • EBS quarterly revenue is now -68.04% below its all-time high of $723.20 million, reached on December 31, 2021.

Performance

EBS Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEBSincome statement metrics

TTM Revenue:

$788.90M-$62.70M(-7.36%)
September 30, 2025

Summary

  • As of today, EBS TTM revenue is $788.90 million, with the most recent change of -$62.70 million (-7.36%) on September 30, 2025.
  • Over the past year, EBS TTM revenue has dropped by -$336.60 million (-29.91%).
  • EBS TTM revenue is now -55.99% below its all-time high of $1.79 billion, reached on December 31, 2021.

Performance

EBS TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEBSincome statement metrics

EBS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-0.5%-21.3%-29.9%
3Y3 Years-41.2%-3.7%-47.9%
5Y5 Years-5.6%-40.0%-40.8%

EBS Revenue Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-41.2%at low-31.6%+64.0%-47.9%at low
5Y5-Year-41.2%at low-68.0%+64.0%-56.0%at low
All-TimeAll-Time-41.2%+2203.3%-68.0%>+9999.0%-56.0%+3679.3%

EBS Revenue History

DateAnnualQuarterlyTTM
Sep 2025
-
$231.10M(+64.0%)
$788.90M(-7.4%)
Jun 2025
-
$140.90M(-36.6%)
$851.60M(-11.8%)
Mar 2025
-
$222.20M(+14.1%)
$965.40M(-7.5%)
Dec 2024
$1.04B(-0.5%)
$194.70M(-33.7%)
$1.04B(-7.3%)
Sep 2024
-
$293.80M(+15.4%)
$1.13B(+2.1%)
Jun 2024
-
$254.70M(-15.2%)
$1.10B(-7.0%)
Mar 2024
-
$300.40M(+8.6%)
$1.19B(+13.0%)
Dec 2023
$1.05B(-6.1%)
$276.60M(+2.3%)
$1.05B(-4.9%)
Sep 2023
-
$270.50M(-19.9%)
$1.10B(+2.9%)
Jun 2023
-
$337.90M(+105.7%)
$1.07B(+9.7%)
Mar 2023
-
$164.30M(-50.3%)
$977.60M(-12.8%)
Dec 2022
$1.12B(-37.0%)
$330.70M(+37.8%)
$1.12B(-25.9%)
Sep 2022
-
$239.90M(-1.2%)
$1.51B(-5.6%)
Jun 2022
-
$242.70M(-21.1%)
$1.60B(-8.8%)
Mar 2022
-
$307.50M(-57.5%)
$1.76B(-2.0%)
Dec 2021
$1.77B(+14.0%)
$723.20M(+119.8%)
$1.79B(+8.5%)
Sep 2021
-
$329.00M(-17.2%)
$1.65B(-3.3%)
Jun 2021
-
$397.50M(+15.9%)
$1.71B(+0.2%)
Mar 2021
-
$343.00M(-41.2%)
$1.71B(+9.7%)
Dec 2020
$1.56B(+40.6%)
$583.00M(+51.3%)
$1.56B(+16.7%)
Sep 2020
-
$385.20M(-2.4%)
$1.33B(+5.8%)
Jun 2020
-
$394.70M(+105.0%)
$1.26B(+13.7%)
Mar 2020
-
$192.50M(-46.6%)
$1.11B(+0.2%)
Dec 2019
$1.11B(+41.4%)
$360.40M(+15.6%)
$1.11B(+8.8%)
Sep 2019
-
$311.80M(+28.2%)
$1.02B(+15.7%)
Jun 2019
-
$243.20M(+27.6%)
$878.15M(+2.7%)
Mar 2019
-
$190.60M(-29.6%)
$855.15M(+9.3%)
Dec 2018
$782.40M(+39.5%)
$270.70M(+55.9%)
$782.37M(+10.9%)
Sep 2018
-
$173.65M(-21.1%)
$705.48M(+3.6%)
Jun 2018
-
$220.20M(+86.9%)
$681.26M(+21.3%)
Mar 2018
-
$117.81M(-39.2%)
$561.83M(+0.2%)
Dec 2017
$560.90M(+14.8%)
$193.81M(+29.7%)
$560.87M(+8.1%)
Sep 2017
-
$149.43M(+48.3%)
$518.73M(+1.3%)
Jun 2017
-
$100.77M(-13.8%)
$512.21M(+1.9%)
Mar 2017
-
$116.86M(-22.9%)
$502.68M(+2.8%)
Dec 2016
$488.78M(-0.1%)
$151.66M(+6.1%)
$488.78M(-1.6%)
Sep 2016
-
$142.91M(+56.6%)
$496.90M(-3.0%)
Jun 2016
-
$91.24M(-11.4%)
$512.37M(-6.4%)
Mar 2016
-
$102.96M(-35.6%)
$547.24M(+7.7%)
Dec 2015
$489.33M
$159.78M(+0.9%)
$507.91M(+2.4%)
Sep 2015
-
$158.38M(+25.6%)
$496.10M(+4.3%)
Jun 2015
-
$126.11M(+98.2%)
$475.67M(+3.4%)
DateAnnualQuarterlyTTM
Mar 2015
-
$63.63M(-57.0%)
$459.89M(+2.2%)
Dec 2014
$450.14M(+43.9%)
$147.97M(+7.3%)
$450.14M(+12.5%)
Sep 2014
-
$137.95M(+25.0%)
$400.27M(+13.9%)
Jun 2014
-
$110.33M(+104.7%)
$351.42M(+8.6%)
Mar 2014
-
$53.88M(-45.1%)
$323.53M(+3.4%)
Dec 2013
$312.75M(+10.9%)
$98.11M(+10.1%)
$312.75M(+1.1%)
Sep 2013
-
$89.10M(+8.1%)
$309.24M(+7.9%)
Jun 2013
-
$82.44M(+91.3%)
$286.73M(+4.4%)
Mar 2013
-
$43.10M(-54.4%)
$274.68M(-2.6%)
Dec 2012
$281.89M(+3.1%)
$94.61M(+42.1%)
$281.89M(-4.5%)
Sep 2012
-
$66.59M(-5.4%)
$295.23M(+2.7%)
Jun 2012
-
$70.38M(+39.9%)
$287.40M(-5.8%)
Mar 2012
-
$50.31M(-53.4%)
$305.16M(+11.6%)
Dec 2011
$273.38M(-4.5%)
$107.95M(+83.7%)
$273.38M(+1.7%)
Sep 2011
-
$58.76M(-33.3%)
$268.68M(-5.4%)
Jun 2011
-
$88.14M(+375.6%)
$283.91M(+10.1%)
Mar 2011
-
$18.53M(-82.0%)
$257.90M(-9.9%)
Dec 2010
$286.17M(+21.9%)
$103.25M(+39.5%)
$286.17M(+20.9%)
Sep 2010
-
$73.99M(+19.1%)
$236.73M(+14.9%)
Jun 2010
-
$62.14M(+32.8%)
$206.01M(-5.1%)
Mar 2010
-
$46.80M(-13.0%)
$217.07M(-7.5%)
Dec 2009
$234.79M(+31.5%)
$53.80M(+24.3%)
$234.79M(+8.3%)
Sep 2009
-
$43.27M(-40.9%)
$216.73M(-5.8%)
Jun 2009
-
$73.19M(+13.4%)
$230.06M(+14.8%)
Mar 2009
-
$64.52M(+80.5%)
$200.35M(+12.2%)
Dec 2008
$178.55M(-2.4%)
$35.75M(-36.8%)
$178.55M(-23.2%)
Sep 2008
-
$56.60M(+30.2%)
$232.44M(+5.9%)
Jun 2008
-
$43.48M(+1.8%)
$219.49M(+10.2%)
Mar 2008
-
$42.72M(-52.3%)
$199.19M(+8.9%)
Dec 2007
$182.91M(+19.8%)
$89.64M(+105.4%)
$182.91M(+1.5%)
Sep 2007
-
$43.64M(+88.2%)
$180.17M(+32.0%)
Jun 2007
-
$23.19M(-12.3%)
$136.52M(+20.5%)
Mar 2007
-
$26.45M(-69.6%)
$113.34M(+30.4%)
Dec 2006
$152.73M(+16.9%)
$86.89M(>+9900.0%)
$86.89M(+316.3%)
Dec 2005
$130.69M(+56.5%)
-
-
Dec 2004
$83.49M(+49.7%)
-
-
Sep 2004
-
$0.00(0.0%)
$20.87M(0.0%)
Jun 2004
-
$0.00(-100.0%)
$20.87M(0.0%)
Mar 2004
-
$20.87M
$20.87M
Dec 2003
$55.77M(-29.0%)
-
-
Dec 2002
$78.54M(+73.3%)
-
-
Dec 2001
$45.31M
-
-

FAQ

  • What is Emergent BioSolutions Inc. annual revenue?
  • What is the all-time high annual revenue for Emergent BioSolutions Inc.?
  • What is Emergent BioSolutions Inc. annual revenue year-on-year change?
  • What is Emergent BioSolutions Inc. quarterly revenue?
  • What is the all-time high quarterly revenue for Emergent BioSolutions Inc.?
  • What is Emergent BioSolutions Inc. quarterly revenue year-on-year change?
  • What is Emergent BioSolutions Inc. TTM revenue?
  • What is the all-time high TTM revenue for Emergent BioSolutions Inc.?
  • What is Emergent BioSolutions Inc. TTM revenue year-on-year change?

What is Emergent BioSolutions Inc. annual revenue?

The current annual revenue of EBS is $1.04B

What is the all-time high annual revenue for Emergent BioSolutions Inc.?

Emergent BioSolutions Inc. all-time high annual revenue is $1.77B

What is Emergent BioSolutions Inc. annual revenue year-on-year change?

Over the past year, EBS annual revenue has changed by -$5.70M (-0.54%)

What is Emergent BioSolutions Inc. quarterly revenue?

The current quarterly revenue of EBS is $231.10M

What is the all-time high quarterly revenue for Emergent BioSolutions Inc.?

Emergent BioSolutions Inc. all-time high quarterly revenue is $723.20M

What is Emergent BioSolutions Inc. quarterly revenue year-on-year change?

Over the past year, EBS quarterly revenue has changed by -$62.70M (-21.34%)

What is Emergent BioSolutions Inc. TTM revenue?

The current TTM revenue of EBS is $788.90M

What is the all-time high TTM revenue for Emergent BioSolutions Inc.?

Emergent BioSolutions Inc. all-time high TTM revenue is $1.79B

What is Emergent BioSolutions Inc. TTM revenue year-on-year change?

Over the past year, EBS TTM revenue has changed by -$336.60M (-29.91%)
On this page